Derma Sciences Financial Statements
Derma Sciences Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Derma Sciences Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 34.1 | 27.9 | 23.5 |
| Gross Profit ($ mil.) | 11.6 | 9.6 | 7.8 |
| Operating Income ($ mil.) | (1.3) | 1.1 | (0.6) |
| Total Net Income ($ mil.) | (2.3) | 0.7 | (0.9) |
| Diluted EPS (Net Income) | (0.09) | 0.03 | (0.07) |
Derma Sciences Stock Quote & Chart
07/24/08 14:58:16 EST •
NASDAQ OTC BB •
0.70
•
 -0.0500
•
-6.6667 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Derma Sciences Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.89 | 2.11 | 1.53 |
| Price/Earnings Ratio | -- | 20.19 | 15.19 |
| Price/Book Ratio | 1.80 | 2.08 | 1.47 |
| Price/Cash Flow Ratio | -- | 15.27 | 9.51 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Derma Sciences Financial Ratios
Derma Sciences Competitive Intelligence
| ConvaTec | Covidien | Johnson & Johnson | |
|---|---|---|---|
| Annual Sales ($ mil.) | 744.0 | 10,170.0 | 61,095.0 |
| Employees | 3,000 | 43,800 | -- |
| Market Cap ($ mil.) | -- | 24,469.4 | 189,017.4 |
Competitive Landscape
